Examkin

Tüm alıştırma soruları

4736 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 1421Soru →

A hospital epidemiology task force is reviewing several changes to diagnostic testing protocols. Match each clinical or administrative intervention with its resulting impact on the statistical performance of the diagnostic test.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

To reduce unnecessary biopsies, a clinic decides to increase the prostate-specific antigen (PSA) threshold for cancer screening from 4.0 ng/mL to 5.5 ng/mL.
A rapid streptococcal antigen test is used in a primary care clinic strictly for patients with a Centor score of 4, rather than all patients presenting with any sore throat.
To minimize missed cases during an outbreak of a severe hemorrhagic fever, health authorities lower the minimum core body temperature required to trigger mandatory quarantine.
A highly sensitive D-dimer assay, typically used to rule out pulmonary embolism in symptomatic patients, is inappropriately applied as a universal screening tool in healthy asymptomatic factory workers.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Cutoff threshold changes alter inherent test characteristics (sensitivity/specificity), moving the operating point along the ROC curve. Changing the tested population alters disease prevalence, which changes the predictive values (PPV/NPV) while keeping inherent test characteristics constant.
Interventions that change a test's cutoff value directly impact sensitivity and specificity, reflecting a movement along the test's ROC curve. Interventions that change the clinical population being tested alter the pretest probability (prevalence), which mathematically shifts the PPV and NPV without changing the test's inherent diagnostic accuracy.

Adım Adım Çözüm

1
Analyze whether each intervention alters the test's positivity threshold or the tested population's disease prevalence.
Items 1 and 3 alter the cutoff threshold. Items 2 and 4 alter the population prevalence.
This determines which statistical parameters will be affected.
2
Determine the direction of change for cutoff threshold interventions.
Raising a cutoff (Item 1) decreases sensitivity and increases specificity. Lowering a cutoff (Item 3) increases sensitivity and decreases specificity.
Higher cutoffs require more extreme values to be 'positive', thus capturing fewer true positives and fewer false positives.
3
Determine the direction of change for population prevalence interventions.
Testing higher-risk patients (Item 2) increases prevalence, which increases PPV and decreases NPV. Testing lower-risk patients (Item 4) decreases prevalence, which decreases PPV and increases NPV.
Bayes' theorem dictates that predictive values are highly dependent on pretest probability (prevalence).

Anahtar Kavram

Changes in test cutoffs affect sensitivity and specificity (moving the ROC point), whereas changes in population prevalence affect PPV and NPV without altering inherent test characteristics.
Soru 1422Soru →

A 62-year-old man is evaluated in the clinic for optimization of his cardiovascular medications. He has a history of type 2 diabetes mellitus, hypertension, and a myocardial infarction 3 years ago. He currently takes maximal medical therapy, including a high-intensity statin. The physician is considering adding a newly approved oral non-statin lipid-lowering medication.

A recent multinational, randomized controlled trial evaluated this medication in a generalized post-myocardial infarction population. Over a 5-year follow-up period, patients in the placebo arm (who were on standard medical therapy) had a 10%10\% incidence of major adverse cardiovascular events (MACE). The new medication demonstrated a 25%25\% relative risk reduction (RRR) in MACE compared to placebo.

The physician uses a validated clinical risk score incorporating the patient's specific metabolic and cardiovascular parameters and estimates that this particular patient has a 28%28\% baseline probability of experiencing MACE over the next 5 years if he remains on his current regimen.

Assuming the relative risk reduction provided by the new medication is constant across different baseline risk profiles, how many patients with a clinical profile identical to this man's must be treated with the new medication for 5 years to prevent one additional MACE?

Cevabı ve açıklamayı göster

Cevap: 15

Cevap

15
To determine the true clinical impact of a medication for a specific patient, physicians must calculate an individualized Number Needed to Treat (NNT). While Relative Risk Reduction (RRR) typically remains constant across various patient groups, Absolute Risk Reduction (ARR) and NNT vary inversely with the patient's baseline risk.

First, identify the patient's individualized baseline risk (Control Event Rate, CER), which is given as 28%28\% (0.280.28). Next, apply the trial's RRR (25%25\% or 0.250.25) to calculate the patient-specific ARR using the formula ARR=CER×RRR\text{ARR} = \text{CER} \times \text{RRR}.

ARR=0.28×0.25=0.07\text{ARR} = 0.28 \times 0.25 = 0.07 (or 7%7\%).

Then, calculate the NNT by taking the inverse of the ARR: NNT=1/0.07=14.28\text{NNT} = 1 / 0.07 = 14.28.

Finally, epidemiological convention requires that NNT is always rounded UP to the next whole integer to ensure at least one full event is prevented. Therefore, 14.2814.28 rounds up to 1515.

Adım Adım Çözüm

1
Identify the patient's individualized baseline risk of the event.
The patient's Control Event Rate (CER) is 28%28\% or 0.280.28.
Number Needed to Treat (NNT) is a patient-specific absolute metric that heavily depends on the individual's baseline risk, not just the generalized trial population's risk.
2
Identify the expected relative benefit of the intervention.
The Relative Risk Reduction (RRR) from the trial is 25%25\% or 0.250.25.
Relative risk metrics generally remain constant across different risk strata and can be applied to individual patients.
3
Calculate the patient-specific Absolute Risk Reduction (ARR).
ARR = CER \times RRR = 0.28×0.25=0.070.28 \times 0.25 = 0.07 (or 7%7\%).
ARR determines the actual absolute difference in outcomes for this specific patient population.
4
Calculate the Number Needed to Treat (NNT).
NNT = 1/ARR=1/0.07≈14.281 / \text{ARR} = 1 / 0.07 \approx 14.28.
NNT represents the number of patients that must be treated to prevent one adverse event.
5
Apply the rounding convention for NNT.
Round 14.2814.28 up to 1515.
NNT is always rounded up to the next highest whole integer to guarantee the prevention of at least one whole event.

Anahtar Kavram

Individualizing Number Needed to Treat (NNT) by applying a trial's Relative Risk Reduction (RRR) to a patient's specific baseline risk (Control Event Rate).
Soru 1423Soru →

A 59-year-old woman is being transferred from the intensive care unit (ICU) to the general medical floor after a 3-day admission for diabetic ketoacidosis. The ICU resident contacts the receiving day-shift ward resident to provide a verbal sign-out. The ICU resident details the patient's hospital course, notes that the anion gap has closed, and states that the patient was transitioned to a subcutaneous insulin regimen two hours ago. A point-of-care blood glucose checked 30 minutes ago was 185 mg/dL (10.3 mmol/L). The ICU resident concludes the handoff by saying, "Her morning basic metabolic panel was drawn an hour ago and is still pending, but she should be fine. Just keep an eye on her blood glucose and give correction doses if needed." Which of the following is the most appropriate action for the receiving resident to take to ensure a safe transition of care?

Cevabı ve açıklamayı göster

Cevap: Elicit specific clinical thresholds for re-evaluating the insulin regimen and clarify which provider is responsible for acting on the pending basic metabolic panel.

Cevap

Elicit specific clinical thresholds for re-evaluating the insulin regimen and clarify which provider is responsible for acting on the pending basic metabolic panel.
The handoff provided by the intensive care unit resident is unstructured and contains critical patient safety vulnerabilities: vague contingency planning ('keep an eye on her') and ambiguous task ownership ('her morning basic metabolic panel... is still pending'). High-quality transitions of care require explicit 'if-then' contingency plans (e.g., defining exact blood glucose parameters that require notification) and clear closed-loop communication establishing who is responsible for following up on pending tests. Eliciting specific thresholds and clarifying task ownership directly mitigates these vulnerabilities and aligns with standardized handoff frameworks like I-PASS.

Adım Adım Çözüm

1
Analyze the handoff communication for missing critical elements.
Identified that the handoff lacks specific 'if-then' contingency plans for blood glucose management and leaves ownership of the pending basic metabolic panel ambiguous.
Standardized handoffs require explicit Action Lists (task ownership) and Situation Awareness/Contingency Planning to prevent errors.
2
Evaluate the clinical status of the patient based on the provided information.
The patient has a closed anion gap, is tolerating subcutaneous insulin, and has a mildly elevated but expected blood glucose of 185 mg/dL.
Determines if the patient is appropriate for transfer and whether immediate clinical intervention is required.
3
Select the action that directly addresses the systemic vulnerabilities in the transition of care.
Choosing to clarify thresholds and task ownership corrects the communication deficit without initiating unnecessary tests or inappropriate dispositions.
The primary issue is a systems-based communication failure, not an acute medical emergency.

Anahtar Kavram

Transitions of Care and Handoff Protocols (Structured Communication)
Tahmini Süre:1m 30s
Soru 1424Soru →

A 45-year-old man is recovering in the surgical intensive care unit following an exploratory laparotomy. He is receiving intravenous fentanyl via a patient-controlled analgesia (PCA) pump. Due to a software malfunction in the device, the pump inadvertently delivers a massive continuous bolus of the opioid. The patient suffers respiratory arrest. The care team successfully initiates cardiopulmonary resuscitation, administers naloxone, and places the patient on mechanical ventilation. His vital signs are subsequently stabilized.

Arrange the following subsequent medicolegal and administrative steps in the correct chronological order to properly manage this adverse event.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Sequester the equipment, Notify risk management, Disclose to the family, Document the events and disclosure, and finally Participate in the root cause analysis.
The management of a severe device-related adverse event requires a stepwise approach that balances clinical safety, medicolegal risk, and ethical obligations. After patient stabilization, the immediate priority is removing the defective device to prevent further harm and preserve evidence (Safe Medical Devices Act requirement). Risk management must then be notified to guide the legal and communicative approach. Following this, the physician fulfills their ethical duty by disclosing the facts to the patient's surrogate. The physician must then document this objective clinical course and the occurrence of the disclosure in the chart. Finally, the long-term response involves a root cause analysis to address system vulnerabilities.

Adım Adım Çözüm

1
Determine the immediate physical safety and evidence preservation requirements.
Sequester the PCA pump and associated materials.
Once the patient is stable, preventing further harm to others (by removing the defective device) and preserving forensic evidence takes highest priority.
2
Determine the appropriate internal reporting channel.
Notify risk management.
Institutional risk management must be aware of sentinel events immediately to provide legal guidance and support the disclosure process.
3
Determine the ethical obligation for communication.
Disclose the event to the patient's family/surrogate.
Physicians have an ethical duty to promptly and honestly inform patients or their surrogates about adverse events and unanticipated outcomes.
4
Determine the medicolegal documentation requirement.
Document the facts and the disclosure in the electronic health record.
A factual, objective note detailing the clinical interventions and noting that the family was informed must be entered into the legal medical record.
5
Determine the long-term systems improvement process.
Participate in the root cause analysis (RCA).
The RCA is a retrospective process requiring time, dedicated personnel, and data analysis to prevent future systemic failures.

Anahtar Kavram

Following a severe adverse event involving a medical device, clinicians must prioritize patient stabilization, immediately sequester evidence, notify risk management, conduct factual disclosure, document objectively, and participate in systemic root cause analysis.
Soru 1425Soru →

A 31-year-old woman is admitted to the inpatient psychiatric unit for an acute manic episode and is started on haloperidol. On hospital day 4, she develops a fever of 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), severe muscle rigidity, and tachycardia. The floor nurse assumes these findings are related to psychiatric catatonia and does not notify the covering physician for four hours. When the physician eventually evaluates the patient, neuroleptic malignant syndrome is immediately recognized. The physician orders transfer to the intensive care unit and STAT administration of intravenous dantrolene. However, the hospital's medication distribution policy requires a multi-step, sequential approval process from the central pharmacy director to release rarely used emergency medications to psychiatric units. This policy delays the administration of dantrolene by an additional two hours. The patient subsequently develops acute kidney injury secondary to rhabdomyolysis.

Which of the following terms best categorizes the hospital's restrictive approval policy for emergency medications?

Cevabı ve açıklamayı göster

Cevap: Latent error

Cevap

Latent error
The hospital's restrictive medication approval policy is a latent error (blunt-end error). Latent errors are systemic flaws embedded in the design, organization, policies, or environment of a healthcare system. They do not immediately cause harm on their own but create conditions that either allow active errors to occur or exacerbate the consequences of clinical emergencies. In this scenario, the bureaucratic policy structurally hindered the timely delivery of emergency care, making it a latent error.

Adım Adım Çözüm

1
Analyze the clinical incident to identify the different types of failures that occurred during the patient's care.
Two main issues occurred: the nurse's delayed notification (an individual action) and the multi-step approval policy delaying medication (a system-level rule).
Distinguishing between the actions of individual frontline operators and the role of overarching system policies is essential for accurately categorizing medical errors.
2
Categorize the specific focus of the question, which is the hospital's restrictive medication approval policy.
The policy is a system-level organizational rule that hindered the timely delivery of emergency care at the 'blunt end' of the system.
System-level flaws that create conditions for harm, rather than direct actions by healthcare workers, meet the definition of a latent error.

Anahtar Kavram

Latent errors are systemic, organizational flaws (e.g., policies, structural design) that create conditions where active errors can occur or where patient harm is exacerbated.
Soru 1426Soru →

A 70-year-old man is admitted to the intensive care unit with a large acute intraparenchymal hemorrhage. The admitting resident is rapidly placing admission orders using the hospital's standard electronic order set for ICU admissions. The resident is aware that deep vein thrombosis (DVT) is a major risk for immobilized ICU patients. Following the standard ICU admission algorithm, the resident selects "subcutaneous heparin" for DVT prophylaxis. The resident does this intentionally, believing it is the correct protocol for all immobilized patients, but fails to recognize that acute intracranial bleeding is an absolute contraindication to pharmacologic anticoagulation. The patient receives the heparin and subsequently suffers neurological deterioration due to hematoma expansion. Which of the following best classifies the cognitive mechanism of the resident's prescribing error?

Cevabı ve açıklamayı göster

Cevap: Rule-based mistake

Cevap

The resident's error is best classified as a rule-based mistake.
The correct classification is a rule-based mistake. In human error taxonomy, a 'mistake' occurs when the intended action goes exactly as planned, but the underlying plan itself is flawed. A 'rule-based' mistake specifically happens when a provider applies a generally correct clinical rule (e.g., 'immobilized ICU patients require DVT prophylaxis') but fails to recognize that the specific patient context makes the rule inappropriate or contraindicated (e.g., an active intracerebral hemorrhage). The resident did not make a physical error in ordering (slip) or forget to order (lapse), nor were they in a completely novel situation requiring first-principles problem-solving (knowledge-based mistake).

Adım Adım Çözüm

1
Analyze the nature of the error in the clinical vignette.
The resident intentionally ordered heparin based on a general rule for ICU patients, missing the contraindication of active bleeding.
Determining the intent and awareness of the provider is necessary to accurately classify the human error.
2
Differentiate between an execution error and a planning error.
The execution was correct (the resident ordered exactly what they intended to order), but the plan was flawed. This rules out execution failures (slips and lapses).
Slips and lapses are execution failures; mistakes are planning failures.
3
Determine the type of planning error (mistake).
The resident applied a familiar 'if-then' rule inappropriately to an exception, rather than problem-solving in a completely novel situation.
Applying a well-known rule to the wrong situation defines a rule-based mistake, distinguishing it from a knowledge-based mistake.

Anahtar Kavram

According to James Reason's taxonomy of human error, active errors are classified into slips (execution failures), lapses (memory failures), mistakes (planning failures), and violations (intentional deviations). Mistakes are further divided into rule-based (misapplying a known rule) and knowledge-based (failing to problem-solve accurately in novel situations).
Soru 1427Soru →

A 42-year-old man comes to the urgent care clinic complaining of fever, severe myalgias, and a retro-orbital headache for the past 3 days. He recently returned from a business trip to a tropical region experiencing an outbreak of a novel mosquito-borne viral illness. The local health department recently provided urgent care centers with a new rapid antigen test for this virus. According to the validation literature provided with the test kits, the test has a sensitivity of 90% and a specificity of 90%. The literature notes that in the validation cohort, which consisted of highly symptomatic patients admitted to a tropical disease hospital, the prevalence of the disease was 50%. However, an epidemiological alert for your specific community urgent care setting estimates the prevalence of this viral illness among patients presenting with similar symptoms to be 10%. The physician performs the rapid antigen test on this patient, and the result is positive.

Based on the epidemiological data for this urgent care setting, which of the following is the best estimate of the probability that this patient actually has the novel viral illness?

Cevabı ve açıklamayı göster

Cevap: 50%

Cevap

50%
The probability that a patient with a positive test actually has the disease is defined as the Positive Predictive Value (PPV). Unlike sensitivity and specificity, which are intrinsic properties of the test, PPV is highly dependent on the disease prevalence in the tested population. In this urgent care setting, the prevalence is 10%. Using a hypothetical cohort of 1,000 patients, 100 will have the disease and 900 will not. With a sensitivity of 90%, there will be 90 true positives. With a specificity of 90%, 810 of the 900 healthy individuals will appropriately test negative, leaving 90 false positives. The total number of positive test results is 180 (90 true positives + 90 false positives). The PPV is the ratio of true positives to total positive results: 90/180=50%90 / 180 = 50\%. Therefore, despite the test's high sensitivity and specificity, the low prevalence in this setting means a positive result is essentially a coin flip.

Adım Adım Çözüm

1
Identify the goal and the relevant testing population parameters.
The goal is to find the Positive Predictive Value (PPV) in the urgent care setting. The prevalence (pre-test probability) is 10%, sensitivity is 90%, and specificity is 90%.
PPV depends heavily on the disease prevalence of the specific testing population. The 50% prevalence from the validation cohort is no longer applicable.
2
Construct a hypothetical cohort of 1,000 patients to represent the urgent care population.
With a 10% prevalence, 100 patients have the disease and 900 do not.
Using a fixed population size makes it straightforward to calculate the raw numbers of true positives and false positives without complex formulas.
3
Calculate the number of True Positives (TP).
100×0.90=90100 \times 0.90 = 90 True Positives.
Sensitivity (90%) is the proportion of patients with the disease who correctly test positive.
4
Calculate the number of False Positives (FP).
Specificity is 90%, meaning 900×0.90=810900 \times 0.90 = 810 True Negatives. The remaining 900−810=90900 - 810 = 90 patients are False Positives.
False positives occur in the healthy population when the test incorrectly returns a positive result (1−Specificity1 - \text{Specificity}).
5
Calculate the Positive Predictive Value (PPV).
PPV=TPTP+FP=9090+90=90180=50%PPV = \frac{TP}{TP + FP} = \frac{90}{90 + 90} = \frac{90}{180} = 50\%.
PPV represents the probability that a patient with a positive test result actually has the disease.

Anahtar Kavram

Positive Predictive Value (PPV) calculation in shifting prevalence settings
Soru 1428Soru →

A 72-year-old man who was admitted 5 days ago for a severe exacerbation of chronic obstructive pulmonary disease has had an indwelling urinary catheter in place since admission due to acute urinary retention. He now has a temperature of 38.4°C (101.1°F) and new-onset suprapubic discomfort. The physician orders a urinalysis and urine culture to evaluate for a possible catheter-associated urinary tract infection (CAUTI). Arrange the following steps for obtaining the urine specimen in the most appropriate chronological order to ensure an uncontaminated sample and maintain the integrity of the closed urinary drainage system.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Clamp the drainage tubing, cleanse the sampling port, aspirate the urine with a syringe, unclamp the tubing, and transfer the specimen to a sterile container.
The correct sequence ensures an uncontaminated, highly representative urine sample while protecting the patient from complications. Clamping the tube ensures fresh urine is sampled for an accurate culture. Disinfecting the port prevents environmental contamination. Using a syringe maintains the closed system. Prompt unclamping prevents iatrogenic urinary retention, and transferring the sample readies it for lab analysis.

Adım Adım Çözüm

1
Identify the goal of the procedure.
The goal is to obtain a sterile urine sample for culture from a patient with an indwelling catheter without introducing infection.
Proper technique prevents both false-positive CAUTI diagnoses and the introduction of new pathogens.
2
Determine the proper source of the sample within the system.
The sample must be taken from fresh urine accumulating in the tubing, not from the collection bag.
Urine in the collection bag sits at room temperature and allows for rapid bacterial overgrowth, leading to inaccurate culture results.
3
Sequence the technical steps for aseptic collection.
First, clamp the tubing to collect fresh urine. Next, disinfect the port to prevent contamination. Then, aspirate the sample with a sterile syringe.
This progression safely acquires fresh urine while strictly maintaining a closed drainage system, which is the primary defense against CAUTI.
4
Sequence the post-collection safety and administrative steps.
Immediately unclamp the tubing, then transfer the urine to a laboratory container.
Unclamping immediately is critical to prevent iatrogenic bladder distension and potential urinary reflux, avoiding patient harm before finishing sample processing.

Anahtar Kavram

Aseptic technique for obtaining urine cultures from an indwelling catheter to prevent CAUTI and false-positive laboratory results.
Tahmini Süre:1m 0s
Soru 1429Soru →

A hospital quality improvement committee is reviewing recent rapid response team activations to identify deficiencies in overnight transitions of care. They analyze a case involving a 48-year-old man admitted for severe acute pancreatitis. The day-shift physician signed out the patient to the cross-cover night physician at 6:00 PM with the following written communication: "48M with severe acute pancreatitis. Has received 4.5 liters of lactated Ringer solution so far today. Vitals currently stable. Plan: Continue aggressive IV fluid resuscitation at 250 mL/hr. Monitor urine output closely." At 2:00 AM, the rapid response team was called for acute-onset hypoxemia and respiratory distress, culminating in intubation for acute respiratory distress syndrome (ARDS) and fluid overload. The committee determines that the sign-out lacked an effective "if-then" contingency plan. Which of the following additions to the handoff communication would have best fulfilled the requirement for an actionable contingency plan and potentially mitigated this adverse outcome?

Cevabı ve açıklamayı göster

Cevap: If the patient develops a respiratory rate greater than 24/min or requires new supplemental oxygen, decrease the IV fluid rate to 100 mL/hr and obtain a STAT chest radiograph and arterial blood gas.

Cevap

The statement providing specific physiological triggers (respiratory rate > 24/min or new oxygen requirement) linked to explicit, mitigating actions (decreasing IV fluids and ordering specific diagnostics) is the correct answer.
The correct answer provides an exemplary "if-then" contingency plan, which is a critical component of standardized handoff frameworks like I-PASS. It identifies an objective clinical threshold (respiratory rate > 24/min, new oxygen requirement) and specifies precise, mitigating actions (decrease IV fluids, obtain diagnostics). This ensures the covering physician anticipates the high-risk complication (volume overload/ARDS in pancreatitis) and knows exactly how to intervene safely.

Adım Adım Çözüm

1
Analyze the clinical scenario to identify the primary mechanism of the adverse event.
The patient developed ARDS/fluid overload due to aggressive IV fluid resuscitation for severe acute pancreatitis.
Understanding the clinical complication is necessary to determine what a proper contingency plan should have anticipated.
2
Evaluate the original handoff communication for structural deficiencies based on standard frameworks (e.g., I-PASS).
The handoff included Illness Severity, Patient Summary, and an Action list (continue fluids, monitor urine), but lacked Contingency Planning (if-then instructions for anticipated complications).
Standardized handoffs require anticipating specific risks and providing the cross-cover team with explicit guidance.
3
Assess the options to identify which statement meets the criteria for a robust contingency plan.
Only the correct option pairs an objective, measurable trigger (vital sign changes) with a specific, safe clinical intervention (decreasing fluids and ordering tests).
Vague instructions ('evaluate if deteriorates') or clinically inappropriate interventions do not fulfill the requirement for an actionable safety net.

Anahtar Kavram

Actionable Contingency Planning in Handoffs
Tahmini Süre:1m 30s
Soru 1430Soru →

A 64-year-old man with a 30-pack-year smoking history is evaluated in the clinic for a solitary pulmonary nodule incidentally found on a chest radiograph. Based on clinical and radiographic features, the physician estimates his pre-test probability of malignancy to be 20%20\%. The physician is considering ordering a novel functional imaging study to further risk-stratify the nodule before deciding on an invasive biopsy.

The medical literature states that the new imaging study has a positive likelihood ratio (LR+LR+) of 6.06.0. To safely defer biopsy and continue with serial observation alone if the test is negative, the physician determines that the post-test probability of malignancy must be 4%4\% or less.

Assuming the test is performed, which of the following best represents the patient's post-test probability of malignancy if the result is positive, and what is the maximum acceptable negative likelihood ratio (LR−LR-) of the test to achieve the physician's goal for a negative result?

Cevabı ve açıklamayı göster

Cevap: Post-test probability if positive: 60%60\%; Maximum acceptable LR−LR-: 1/61/6

Cevap

Post-test probability if positive: 60%60\%; Maximum acceptable LR−LR-: 1/61/6
To determine the post-test probability of disease, one must use the odds form of Bayes' theorem (Fagan's theorem). First, convert the pre-test probability (20%20\%) to pre-test odds: 0.20/(1−0.20)=1/40.20 / (1 - 0.20) = 1/4. For a positive test result, multiply the pre-test odds by the LR+LR+ (6.06.0) to get post-test odds of 6/46/4, or 3/23/2. Converting this back to probability yields (3/2)/(1+3/2)=3/5(3/2) / (1 + 3/2) = 3/5, which is 60%60\%. To find the required LR−LR- for a negative result, convert the target post-test probability (4%4\%) to target post-test odds: 0.04/0.96=1/240.04 / 0.96 = 1/24. Because Post-test odds = Pre-test odds ×LR−\times LR-, the maximum acceptable LR−LR- is the Target post-test odds divided by the Pre-test odds: (1/24)/(1/4)=4/24(1/24) / (1/4) = 4/24, which simplifies to 1/61/6.

Adım Adım Çözüm

1
Convert the pre-test probability to pre-test odds.
Pre-test odds = 0.20/(1−0.20)=0.20/0.80=1/40.20 / (1 - 0.20) = 0.20 / 0.80 = 1/4 (or 0.250.25).
Likelihood ratios can only be mathematically applied to odds, not directly to probabilities.
2
Calculate the post-test odds for a positive test result and convert it back to probability.
Post-test odds = Pre-test odds ×LR+=(1/4)×6.0=6/4=3/2\times LR+ = (1/4) \times 6.0 = 6/4 = 3/2 (or 1.51.5). Post-test probability = Odds / (1 + Odds) = (3/2)/(5/2)=3/5=60%(3/2) / (5/2) = 3/5 = 60\%.
This determines the patient's likelihood of malignancy if the imaging study is positive.
3
Convert the target post-test probability for a negative result into target post-test odds.
Target post-test odds = 0.04/(1−0.04)=0.04/0.96=1/240.04 / (1 - 0.04) = 0.04 / 0.96 = 1/24.
To find the required LR−LR-, the target probability goal must first be expressed as odds.
4
Calculate the maximum acceptable LR−LR- required to reach the target post-test odds.
LR−=Target post-test odds/Pre-test odds=(1/24)/(1/4)=4/24=1/6LR- = \text{Target post-test odds} / \text{Pre-test odds} = (1/24) / (1/4) = 4/24 = 1/6.
Fagan's theorem states that Post-test odds = Pre-test odds ×LR\times LR. Rearranging this allows us to solve for the necessary test characteristic.

Anahtar Kavram

Applying Fagan's theorem (Odds form of Bayes' theorem) to calculate post-test probabilities and required likelihood ratios.
Tahmini Süre:2m 30s
Soru 1431Soru →

A clinical epidemiologist is reviewing data from a large national registry for a chronic autoimmune condition. Two years ago, an international consensus committee introduced new diagnostic criteria for this condition. These new criteria incorporate advanced serologic testing, making them significantly more sensitive but slightly less specific than the historical criteria. Consequently, many patients with mild or early-stage symptoms are now formally diagnosed with the condition, whereas previously they were classified as having undifferentiated joint pain. The underlying biological incidence of the disease, the total population size, and the efficacy of available treatments have remained completely stable. Based on these changes, which of the following combinations best describes the expected impact on the reported epidemiological metrics for this condition?

Cevabı ve açıklamayı göster

Cevap: Reported incidence increases, prevalence increases, case fatality rate decreases, and disease-specific mortality rate remains unchanged.

Cevap

Reported incidence increases, prevalence increases, case fatality rate decreases, and disease-specific mortality rate remains unchanged.
The introduction of more sensitive diagnostic criteria artificially inflates the number of patients recognized as having the disease by capturing early and mild cases. This mathematically increases the numerators for both reported incidence (new cases) and prevalence (total cases). Because these mild cases are added to the total diagnosed pool without changing the absolute number of deaths (since treatment efficacy and true biological severity are unchanged), the case fatality rate (deaths per diagnosed cases) becomes diluted and decreases. However, the disease-specific mortality rate (deaths per total population) remains entirely unchanged because neither the absolute number of deaths nor the total population size was altered by the new diagnostic rules.

Adım Adım Çözüm

1
Determine the impact on reported incidence and prevalence.
Both increase.
Highly sensitive criteria identify early and mild cases that were previously missed. This adds more new cases to the numerator for incidence, and more total existing cases to the numerator for prevalence.
2
Analyze the components of Case Fatality Rate (CFR).
CFR decreases.
CFR is calculated as (Deaths from disease) / (Total diagnosed cases). The numerator (deaths) is constant because biology and treatments are unchanged, but the denominator (diagnosed cases) has significantly increased. A constant numerator over a larger denominator results in a lower CFR.
3
Analyze the components of Disease-Specific Mortality Rate.
Disease-specific mortality rate remains unchanged.
Mortality rate is calculated as (Deaths from disease) / (Total population). Both the number of deaths and the total population size are unchanged. Therefore, this metric remains completely stable.

Anahtar Kavram

Impact of changing diagnostic sensitivity on epidemiological metrics (Incidence, Prevalence, Case Fatality Rate, Mortality Rate).
Soru 1432Soru →

A national infectious disease task force is evaluating the epidemiological characteristics of a newly identified strain of avian influenza (H7N9) that recently emerged in a specific geographic region. The task force reviews surveillance data compiled during the first 1212 months of the outbreak. The data are summarized in the table below:

Surveillance MetricNumber of Individuals
Total region population3,500,0003,500,000
Individuals tested for H7N9150,000150,000
Laboratory-confirmed H7N9 cases2,5002,500
H7N9-related hospitalizations1,0001,000
Total deaths (all causes)25,00025,000
H7N9-related deaths400400

Based on the surveillance data provided, which of the following best represents the case fatality rate of this newly identified avian influenza strain?

Cevabı ve açıklamayı göster

Cevap: 16.0%16.0\%

Cevap

16.0%16.0\%
The correct answer is 16.0%16.0\%. The case fatality rate (CFR) measures the severity or lethality of a disease. It is calculated by dividing the number of deaths caused by a specific disease by the total number of people diagnosed with that disease in the same period. In this surveillance scenario, there were 400400 deaths directly attributed to H7N9 and a total of 2,5002,500 laboratory-confirmed cases. Therefore, the CFR is 4002,500\frac{400}{2,500}, which equals 0.160.16, or 16.0%16.0\%.

Adım Adım Çözüm

1
Identify the epidemiological formula for Case Fatality Rate (CFR).
CFR=Deaths from the diseaseTotal confirmed cases of the disease×100%\text{CFR} = \frac{\text{Deaths from the disease}}{\text{Total confirmed cases of the disease}} \times 100\%
CFR measures the lethality of a condition by assessing what proportion of diagnosed individuals ultimately die from it.
2
Extract the necessary data points from the surveillance table.
Deaths from H7N9 = 400400. Laboratory-confirmed H7N9 cases = 2,5002,500.
Only the specific deaths caused by the disease and the total number of individuals definitively diagnosed are required for the calculation.
3
Perform the calculation to find the percentage.
4002,500×100%=0.16×100%=16.0%\frac{400}{2,500} \times 100\% = 0.16 \times 100\% = 16.0\%
Dividing the specific deaths by the total confirmed cases yields the correct case fatality rate.

Anahtar Kavram

The Case Fatality Rate (CFR) is a measure of disease severity, defined as the proportion of fatal cases among those diagnosed with the disease during a specified time period.
Soru 1433Soru →

A physician is faced with several complex ethical dilemmas regarding patient autonomy, decisional capacity, and end-of-life care. Match each clinical scenario to the most appropriate legal or ethical resolution.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient with chronic schizophrenia, currently experiencing auditory hallucinations unrelated to their medical condition, clearly articulates the risks and benefits of a recommended life-saving procedure but refuses it.
An incapacitated patient has a valid advance directive explicitly refusing intubation in their current clinical scenario. However, their legally appointed healthcare proxy demands that the medical team intubate.
An unresponsive, unidentified patient is brought to the emergency department with exsanguinating internal hemorrhage requiring immediate surgical intervention.
A 16-year-old legally married patient with refractory terminal cancer requests to transition to comfort-focused hospice care, but the patient's parents insist on continuing aggressive chemotherapy.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The schizophrenic patient with capacity has the right to refuse care. The advance directive overrides the contradictory proxy. The unrepresented emergency patient is treated under implied consent. The married minor is emancipated and directs their own care.
Each scenario tests a fundamental concept in medical ethics and law. Task-specific capacity is maintained if the patient understands the intervention, regardless of underlying psychiatric illness. Written advance directives represent the highest form of patient autonomy and override surrogate demands. Implied consent allows life-saving emergency treatment when patients cannot consent. Legal emancipation (e.g., through marriage) grants minors full authority to make healthcare decisions, superseding parental wishes.

Adım Adım Çözüm

1
Analyze each scenario for factors affecting legal authority, such as decision-making capacity, age, emergency status, and formal advance directives.
Identified the core conflict in each case: capacity versus psychiatric illness, proxy versus living will, unrepresented emergency patient, and minor versus emancipated minor.
Identifying the legal or ethical bottleneck is necessary to apply the correct USMLE standard.
2
Apply relevant ethical principles and legal doctrines to resolve each conflict.
Matched each scenario to its guiding principle: task-specific capacity, primacy of written advance directives, implied consent, and emancipation exceptions.
Medical jurisprudence dictates clear resolutions for these classic ethical dilemmas.

Anahtar Kavram

Application of Medical Jurisprudence and Ethics in Decision-Making
Soru 1434Soru →

An 8181-year-old female with end-stage renal disease on hemodialysis is admitted to the medical ward for urosepsis. The admitting resident prescribes a standard dose of cefepime. The hospital's computerized provider order entry system does not have an integrated alert requiring dosage adjustment for patients with a glomerular filtration rate below 30 mL/min30 \text{ mL/min}. The order is routed to the central pharmacy, where a single pharmacist is covering 33 distinct wards due to a hospital policy that consolidates coverage during unexpected staffing absences. The pharmacist verifies the order without cross-referencing the patient's renal function. Furthermore, during the afternoon transition of care, the primary day-shift nurse does not communicate the most recent basic metabolic panel results to the incoming night-shift nurse.

Following multiple unadjusted doses of cefepime, the patient develops profound encephalopathy and myoclonus. The cross-covering resident evaluates the patient and attributes the altered mental status solely to sepsis-associated encephalopathy, delaying the recognition of medication toxicity. An event analysis is initiated to evaluate the contributing factors.

Based on the principles of patient safety and error classification, which of the following elements of this incident are categorized as latent system vulnerabilities rather than active failures? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Absence of a forced alert for creatinine clearance mismatch in the medication ordering software; Hospital contingency protocol mandating consolidated ward coverage during unforeseen pharmacy staffing shortages

Cevap

The latent system vulnerabilities are the absence of a forced alert for creatinine clearance mismatch in the medication ordering software and the hospital contingency protocol mandating consolidated ward coverage during unforeseen pharmacy staffing shortages.
Latent system vulnerabilities (blunt-end errors) are flaws in the design, organization, environment, or protocols of a healthcare system that create conditions in which human errors are more likely to occur. The absence of a hard stop or alert for a renal dosing mismatch in the computerized provider order entry system is a systemic design flaw. Similarly, the hospital policy that mandates a single pharmacist to cover an excessive number of wards during staff shortages is an organizational vulnerability that leads to high workload, fatigue, and decreased vigilance. Both of these factors are latent conditions that set the stage for the adverse event.

Adım Adım Çözüm

1
Differentiate between active failures and latent conditions in the context of the Swiss Cheese Model of accident causation.
Active failures occur at the 'sharp end' (frontline personnel directly interacting with patients or systems), while latent conditions occur at the 'blunt end' (organizational, environmental, or system design flaws).
Accurately categorizing errors is the first step in root cause analysis to implement effective, system-wide safety interventions.
2
Evaluate each provided contributing factor against the definitions of active and latent errors.
The missing software alert and the flawed staffing policy are structural/organizational flaws (latent). The incorrect prescribing, the omission during handoff, and the cognitive diagnostic error are immediate unsafe acts by individuals (active).
Identifying which factors are embedded in the system versus which are discrete human actions allows for precise classification.

Anahtar Kavram

Classification of Medical Errors (Active Failures vs. Latent Conditions)
Soru 1435Soru →

A regional health system is reviewing and updating its clinical testing guidelines for several conditions. The quality improvement committee must consider how different modifications to testing protocols impact the statistical performance and clinical utility of these diagnostics. Match each proposed modification in the testing strategy to its corresponding primary statistical consequence.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Testing a highly symptomatic cohort rather than conducting asymptomatic general population screening
Lowering the cutoff threshold for a positive result on a quantitative diagnostic assay
Raising the cutoff threshold for a positive result on a quantitative diagnostic assay
Adopting a new diagnostic assay that demonstrates a greater area under the receiver operating characteristic (ROC) curve

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align changes in disease prevalence with shifts in predictive values, adjustments in cutoff thresholds with their inverse effects on sensitivity and specificity, and the ROC curve area with overall test accuracy.
Each modification directly impacts specific test parameters. Prevalence changes only affect predictive values. Threshold changes force a trade-off between sensitivity and specificity. The area under the ROC curve is a threshold-independent measure of overall accuracy.

Adım Adım Çözüm

1
Evaluate the effect of changing the tested population (prevalence).
Testing symptomatic patients increases disease prevalence, which increases positive predictive value and decreases negative predictive value.
Predictive values are highly dependent on disease prevalence, whereas sensitivity and specificity are not.
2
Analyze the impact of modifying diagnostic cutoff thresholds.
Lowering a cutoff increases sensitivity but decreases specificity. Raising a cutoff increases specificity but decreases sensitivity.
Moving a threshold creates an unavoidable trade-off between capturing true positives (sensitivity) and avoiding false positives (specificity).
3
Interpret the meaning of a larger area under the ROC curve.
It indicates a test with superior overall diagnostic accuracy.
The ROC curve plots sensitivity against 1-specificity across all cutoffs; a greater area represents better overall discriminative ability.

Anahtar Kavram

Understanding how prevalence impacts predictive values, how cutoff shifts inversely alter sensitivity and specificity, and how ROC curves measure overall diagnostic accuracy.
Tahmini Süre:1m 30s
Soru 1436Soru →

A multi-center task force is evaluating the diagnostic performance of a novel quantitative serum biomarker, matrix metalloproteinase-9 (MMP-9), for the early detection of severe joint destruction in patients with rheumatoid arthritis.

Extensive population studies reveal the following about the biomarker's distribution:
- In healthy patients without joint destruction, MMP-9 levels are normally distributed with a mean of 40 ng/mL40 \text{ ng/mL} and a standard deviation of 5 ng/mL5 \text{ ng/mL}.
- In patients with confirmed severe joint destruction, MMP-9 levels are normally distributed with a mean of 60 ng/mL60 \text{ ng/mL} and a standard deviation of 5 ng/mL5 \text{ ng/mL}.

The current diagnostic threshold for a 'positive' screening result is set at ≥50 ng/mL\geq 50 \text{ ng/mL}. However, rheumatologists have noted an unacceptably high number of missed diagnoses (false negatives) using this threshold. To improve the test's sensitivity, the task force officially recommends lowering the cutoff threshold to ≥45 ng/mL\geq 45 \text{ ng/mL}.

Assuming the 68-95-99.7 (empirical) rule applies, by what absolute percentage (percentage points) will the test's specificity decrease as a result of lowering the cutoff from 50 ng/mL50 \text{ ng/mL} to 45 ng/mL45 \text{ ng/mL}?

Cevabı ve açıklamayı göster

Cevap: 13.5

Cevap

13.5
The absolute decrease in specificity is mathematically equivalent to the absolute increase in the false positive rate (FPR). Specificity represents the proportion of healthy individuals who correctly test negative (values below the cutoff). The FPR represents healthy individuals who incorrectly test positive (values above the cutoff). At the original cutoff of 50 ng/mL50 \text{ ng/mL} (+2 SD from the healthy mean), the empirical rule states 2.5% of the healthy population falls in this upper tail, making the initial FPR 2.5%. When the cutoff is lowered to 45 ng/mL45 \text{ ng/mL} (+1 SD), 16% of the healthy population falls in the upper tail, making the new FPR 16%. The absolute increase in false positives is 16%−2.5%=13.5%16\% - 2.5\% = 13.5\%. Consequently, the test's specificity drops by exactly 13.5 percentage points.

Adım Adım Çözüm

1
Identify the population distribution needed for specificity calculations.
Specificity and false positive rates are derived exclusively from the healthy population (mean 40 ng/mL40 \text{ ng/mL}, standard deviation 5 ng/mL5 \text{ ng/mL}).
Specificity is the probability of a negative test in patients who do not have the disease.
2
Calculate the False Positive Rate (FPR) for the original cutoff of 50 ng/mL50 \text{ ng/mL}.
The FPR is 2.5%.
The cutoff 50 ng/mL50 \text{ ng/mL} is exactly 2 standard deviations above the mean of 40. Using the 68-95-99.7 rule, 95% of the area is within ±2 SD\pm 2 \text{ SD}. The remaining 5% is split between two tails, so the area above +2 SD+2 \text{ SD} is 2.5%.
3
Calculate the False Positive Rate (FPR) for the new cutoff of 45 ng/mL45 \text{ ng/mL}.
The FPR is 16%.
The cutoff 45 ng/mL45 \text{ ng/mL} is exactly 1 standard deviation above the mean of 40. Using the empirical rule, 68% of the area is within ±1 SD\pm 1 \text{ SD}. The remaining 32% is split between two tails, so the area above +1 SD+1 \text{ SD} is 16%.
4
Calculate the absolute decrease in specificity.
13.5 percentage points.
Specificity is 100%−FPR100\% - \text{FPR}. The old specificity was 100%−2.5%=97.5%100\% - 2.5\% = 97.5\%. The new specificity is 100%−16%=84%100\% - 16\% = 84\%. The absolute decrease is 97.5%−84%=13.5%97.5\% - 84\% = 13.5\%.

Anahtar Kavram

The quantitative relationship between shifting diagnostic cutoff thresholds, false positive rates (FPR), and specificity within normally distributed populations.
Soru 1437Soru →

Match each epidemiological scenario with the most appropriate measure of disease frequency.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

An investigation of acute gastroenteritis following a catered wedding calculates the proportion of attendees who developed symptoms within 72 hours.
A prospective cohort study of manufacturing workers measures new leukemia diagnoses, accounting for the varying lengths of time each employee was observed.
An oncology registry tracks the proportion of patients newly diagnosed with glioblastoma multiforme who succumb to the condition within a five-year period.
A local health screening initiative assesses the proportion of adults aged 50-65 years who have confirmed hypertension on the exact day they present to the clinic.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align short-term outbreak data with attack rate, person-time observation with incidence rate, disease lethality with case fatality rate, and a snapshot of existing disease with point prevalence.
Each measure of disease frequency has unique mathematical properties. Attack rate applies to distinct, short-term outbreaks. Incidence density must be used when study participants are observed for unequal lengths of time, utilizing person-time in the denominator. Case fatality rate specifically measures the deadliness of a disease by dividing deaths from the disease by the total number of people with the disease. Point prevalence takes a static cross-sectional snapshot, ignoring whether the condition is newly diagnosed or chronic.

Adım Adım Çözüm

1
Analyze the acute gastroenteritis scenario.
The scenario measures new cases over a very short, defined risk period following a specific exposure.
This precisely matches the definition of an Attack Rate.
2
Evaluate the manufacturing worker cohort scenario.
The calculation specifically accounts for varying observation periods among individuals.
When the denominator is person-time rather than a static population count, the metric is Incidence Rate (Incidence Density).
3
Assess the glioblastoma registry scenario.
The metric measures deaths specifically among those already diagnosed with the disease.
Tracking death among the diagnosed population defines the Case Fatality Rate.
4
Examine the hypertension screening scenario.
The scenario identifies all existing cases of a disease in a population at a single moment in time.
A cross-sectional snapshot of disease burden is the Point Prevalence.

Anahtar Kavram

Measures of Disease Frequency
Soru 1438Soru →

A first-year gastroenterology fellow is preparing for an afternoon block of outpatient procedures. Upon entering the private staff lounge, the fellow observes the fellowship program director—who is scheduled to perform the next five colonoscopies—self-administering an intravenous injection. The director quickly conceals the syringe and says, 'I am just taking a vitamin B12 shot for my chronic fatigue.' The fellow notes that the director's pupils are pinpoint and their speech is abnormally slow and slightly slurred. The first patient is in the pre-procedure area and is scheduled to be sedated in 10 minutes. Which of the following is the most ethically and legally appropriate next step for the fellow?

Cevabı ve açıklamayı göster

Cevap: Inform the Chief Medical Officer or equivalent hospital leadership immediately to intervene and prevent the director from performing procedures.

Cevap

Inform the Chief Medical Officer or equivalent hospital leadership immediately to intervene and prevent the director from performing procedures.
The correct answer prioritizes immediate patient safety by utilizing the appropriate administrative channels. The physician in the vignette is exhibiting classic signs of opioid intoxication (miosis, slurred speech, observed IV administration) and is about to perform invasive procedures. The American Medical Association (AMA) Code of Medical Ethics mandates that physicians have a duty to report impaired colleagues. When patient harm is imminent, the reporter must take immediate action to prevent the impaired physician from seeing patients. This is best accomplished by notifying a superior with the administrative authority to suspend the physician's duties, such as a Chief Medical Officer, Chief of Staff, or Department Chair. Subsequently, the physician can be referred to a Physician Health Program (PHP) for evaluation and rehabilitation.

Adım Adım Çözüm

1
Identify the clinical signs of impairment and synthesize the physical findings.
The combination of pinpoint pupils (miosis), slurred speech, lethargy, and observed intravenous injection strongly indicates acute opioid intoxication.
Recognizing the toxidrome is necessary to confidently reject the physician's benign explanation (vitamin B12).
2
Assess the immediate risk to patient safety.
The impaired physician is scheduled to perform invasive endoscopic procedures on sedated patients in 10 minutes, representing an imminent and severe threat to patient safety.
The level of immediacy dictates whether the situation requires emergent intervention versus retrospective reporting.
3
Determine the appropriate ethical and legal reporting mechanism.
The fellow must bypass standard hierarchical deference and immediately notify institutional leadership (such as the Chief Medical Officer, Chief of Staff, or Department Chair).
Institutional leadership has the immediate authority to suspend clinical privileges, protect the patients, and appropriately route the impaired physician to a Physician Health Program (PHP).

Anahtar Kavram

When a physician presents an immediate threat to patient safety due to suspected substance impairment, the first priority is to prevent them from participating in clinical care by immediately notifying institutional leadership.
Soru 1439Soru →

A regional health authority is evaluating strategies to reduce the incidence of ventilator-associated pneumonia (VAP) across its intensive care units. A prospective cohort study within the region yields the following incidence data based on patient positioning:

- Incidence of VAP in patients maintained in a supine position: 30 cases per 1,000 ventilator-days
- Incidence of VAP in patients maintained in a semi-recumbent position: 5 cases per 1,000 ventilator-days

Recent clinical audits indicate that, despite existing guidelines, 60% of all mechanically ventilated patients in the region are currently maintained primarily in the supine position.

The health authority plans to implement a strict quality improvement protocol to eliminate the use of the supine position entirely, successfully transitioning all patients to the semi-recumbent position. Assuming the observed association is entirely causal, what percentage of the total current VAP cases in the region can be attributed to the use of the supine position (and thus would be prevented by this initiative)?

Enter your answer as a whole number.

Cevabı ve açıklamayı göster

Cevap: 75

Cevap

75
The question asks for the percentage of total VAP cases in the population that are attributable to the supine position. This corresponds to the Population Attributable Risk Percent (PAR\%), also known as the Population Attributable Fraction (PAF). To find it, first calculate the overall population incidence (IpopI_{pop}), which is the weighted average based on exposure prevalence: (30×0.60)+(5×0.40)=20(30 \times 0.60) + (5 \times 0.40) = 20 cases per 1,000 ventilator-days. Next, find the Population Attributable Risk (PAR) by subtracting the unexposed incidence from the overall population incidence: 20−5=1520 - 5 = 15. Finally, calculate the PAR\% by dividing the PAR by the overall population incidence: (15/20)×100=75%(15 / 20) \times 100 = 75\%.

Adım Adım Çözüm

1
Calculate the overall incidence of VAP in the entire ICU population (IpopI_{pop}).
Ipop=20I_{pop} = 20 cases per 1,000 ventilator-days.
The population incidence is the weighted average of the incidences in the exposed and unexposed groups, based on the prevalence of the exposure in the population: Ipop=(Iexp×Pexp)+(Iunexp×Punexp)=(30×0.60)+(5×0.40)=18+2=20I_{pop} = (I_{exp} \times P_{exp}) + (I_{unexp} \times P_{unexp}) = (30 \times 0.60) + (5 \times 0.40) = 18 + 2 = 20.
2
Calculate the Population Attributable Risk (PAR).
PAR=15PAR = 15 cases per 1,000 ventilator-days.
PAR represents the excess incidence of disease in the total population that is attributable to the exposure. It is calculated as Ipop−Iunexp=20−5=15I_{pop} - I_{unexp} = 20 - 5 = 15.
3
Calculate the Population Attributable Risk Percent (PAR\%).
PAR%=75%PAR\% = 75\%.
PAR\% (also known as the Population Attributable Fraction) is the proportion of total cases in the population that could be prevented if the exposure were eliminated. It is calculated as (PAR/Ipop)×100=(15/20)×100=75%(PAR / I_{pop}) \times 100 = (15 / 20) \times 100 = 75\%.

Anahtar Kavram

Population Attributable Risk Percent (PAR\%) is the proportion of disease incidence in a total population that can be attributed to a specific exposure, calculated as (Ipop−Iunexp)/Ipop(I_{pop} - I_{unexp}) / I_{pop}.

Alternatif Yöntem

The Population Attributable Fraction (PAF) can also be derived directly using the prevalence of exposure (PexpP_{exp}) and the Relative Risk (RRRR) with Levin's formula: PAF=[Pexp×(RR−1)]/[Pexp×(RR−1)+1]PAF = [P_{exp} \times (RR - 1)] / [P_{exp} \times (RR - 1) + 1]. Here, RR=30/5=6RR = 30 / 5 = 6. Therefore, PAF=[0.60×(6−1)]/[0.60×(6−1)+1]=[0.60×5]/[0.60×5+1]=3/4=75%PAF = [0.60 \times (6 - 1)] / [0.60 \times (6 - 1) + 1] = [0.60 \times 5] / [0.60 \times 5 + 1] = 3 / 4 = 75\%.
Tahmini Süre:1m 30s
Soru 1440Soru →

A research team is utilizing data from a large, prospective occupational health cohort of 80,000 industrial workers established in 2010. The original study collected detailed baseline health questionnaires, DNA samples, and environmental exposure logs. The team now hypothesizes that a specific genetic polymorphism increases the risk of developing three distinct conditions: occupational asthma, noise-induced hearing loss, and contact dermatitis. Because genotyping all 80,000 workers is cost-prohibitive, the investigators select a random sample of 3,000 workers from the baseline cohort to undergo genotyping. They also genotype all workers from the entire 80,000-person cohort who developed any of the three incident conditions between 2010 and 2026. The genotype frequencies of the incident cases for each of the three conditions are then separately compared to the genotype frequencies of the initial 3,000-person sample.

Which of the following best describes this epidemiological study design?

Cevabı ve açıklamayı göster

Cevap: Case-cohort study

Cevap

Case-cohort study
The study described is a case-cohort study. In this specific epidemiological design, a random subcohort is selected from the baseline parent cohort prior to any longitudinal follow-up. This subcohort then serves as the reference group for all incident cases that develop in the entire parent cohort over time. A major logistical and financial advantage of the case-cohort design—as explicitly demonstrated in this scenario—is that a single baseline subcohort can be used as the comparison group for multiple distinct disease outcomes (occupational asthma, noise-induced hearing loss, and contact dermatitis), drastically reducing the costs associated with genotyping or biomarker assays.

Adım Adım Çözüm

1
Identify the parent population and the temporal nature of the data collection.
The study utilizes a large, prospective cohort followed over 16 years (2010-2026).
Establishing the longitudinal nature eliminates cross-sectional and purely retrospective designs.
2
Analyze the specific sampling strategy used to select the non-case comparison group.
A random sample of 3,000 workers is selected at baseline, rather than matching controls to cases at the exact time each diagnosis occurs.
The method of selecting the comparison group is the primary differentiator among advanced epidemiological designs like nested case-control and case-cohort.
3
Evaluate the relationship between the chosen comparison group and the outcomes being studied.
The identical baseline subcohort of 3,000 workers is utilized as the comparison group for three completely different incident outcomes (asthma, hearing loss, dermatitis).
The ability to use one subcohort for multiple outcomes is the defining logistical advantage of a case-cohort design over a nested case-control design.

Anahtar Kavram

Case-cohort study design and its advantage in evaluating multiple outcomes within a parent cohort
ÖncekiSayfa 72 / 237Sonraki
Tüm alıştırma soruları — USMLE Step 3 | Examkin